These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27854202)

  • 1. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
    Rodrigues M; Echigoya Y; Fukada SI; Yokota T
    J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
    Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
    J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
    Blain AM; Greally E; McClorey G; Manzano R; Betts CA; Godfrey C; O'Donovan L; Coursindel T; Gait MJ; Wood MJ; MacGowan GA; Straub VW
    PLoS One; 2018; 13(6):e0198897. PubMed ID: 29912990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.
    Janssen PM; Hiranandani N; Mays TA; Rafael-Fortney JA
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2373-8. PubMed ID: 16024571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.
    Betts CA; McClorey G; Healicon R; Hammond SM; Manzano R; Muses S; Ball V; Godfrey C; Merritt TM; van Westering T; O'Donovan L; Wells KE; Gait MJ; Wells DJ; Tyler D; Wood MJ
    Hum Mol Genet; 2019 Feb; 28(3):396-406. PubMed ID: 30281092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model.
    Yavas A; Weij R; van Putten M; Kourkouta E; Beekman C; Puoliväli J; Bragge T; Ahtoniemi T; Knijnenburg J; Hoogenboom ME; Ariyurek Y; Aartsma-Rus A; van Deutekom J; Datson N
    PLoS One; 2020; 15(12):e0244215. PubMed ID: 33362201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
    Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
    Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
    Lopez JR; Kolster J; Zhang R; Adams J
    J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the bone and growth phenotype of
    Wood CL; Suchacki KJ; van 't Hof R; Cawthorn WP; Dillon S; Straub V; Wong SC; Ahmed SF; Farquharson C
    Dis Model Mech; 2020 Jan; 13(2):. PubMed ID: 31754018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
    Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
    Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
    Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
    Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.